Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Cathomen

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Scientific Reports|December 3, 2016
Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickaseReto Eggenschwiler, Mohsen Moslem, Mariane Serra Fráguas, et al.
Circulation|December 8, 2010
Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulatorMadlen Rother, Stefanie Krohn, Gabriela Kania, et al.
Nature Communications|August 12, 2025
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous diseaseJonas Holst Wolff, Thomas Wisbech Skov, Didde Haslund, et al.
Nature Biotechnology|November 28, 2024
Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterationsGrégoire Cullot, Eric J Aird, Moritz F Schlapansky, et al.
EMBO Molecular Medicine|January 5, 2024
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1Laura Torella, Julia Klermund, Martin Bilbao-Arribas, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2023
Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosisViviane Dettmer-Monaco, Kristoffer Weißert, Sandra Ammann, et al.
Nature Communications|February 25, 2026
ERCC6L2 ensures repair fidelity for staggered-end DNA double-strand breaksEric J Aird, Almudena Serrano-Benitez, Sebastian M Siegner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2015
Genome editing technologies: defining a path to clinicJacqueline Corrigan-Curay, Marina O'Reilly, Donald B Kohn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2025
Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transferWeijie Du, Fatih Noyan, Oliver McCallion, et al.
Cell Reports. Medicine|June 4, 2025
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cellsAnastasia Conti, Kety Giannetti, Federico Midena, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Scientific Reports|December 3, 2016
Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickaseReto Eggenschwiler, Mohsen Moslem, Mariane Serra Fráguas, et al.
Circulation|December 8, 2010
Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulatorMadlen Rother, Stefanie Krohn, Gabriela Kania, et al.
Nature Communications|August 12, 2025
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous diseaseJonas Holst Wolff, Thomas Wisbech Skov, Didde Haslund, et al.
Nature Biotechnology|November 28, 2024
Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterationsGrégoire Cullot, Eric J Aird, Moritz F Schlapansky, et al.
EMBO Molecular Medicine|January 5, 2024
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1Laura Torella, Julia Klermund, Martin Bilbao-Arribas, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2023
Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosisViviane Dettmer-Monaco, Kristoffer Weißert, Sandra Ammann, et al.
Nature Communications|February 25, 2026
ERCC6L2 ensures repair fidelity for staggered-end DNA double-strand breaksEric J Aird, Almudena Serrano-Benitez, Sebastian M Siegner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2015
Genome editing technologies: defining a path to clinicJacqueline Corrigan-Curay, Marina O'Reilly, Donald B Kohn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2025
Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transferWeijie Du, Fatih Noyan, Oliver McCallion, et al.
Cell Reports. Medicine|June 4, 2025
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cellsAnastasia Conti, Kety Giannetti, Federico Midena, et al.
Pageof 18